1. Home
  2. INBX vs BSVN Comparison

INBX vs BSVN Comparison

Compare INBX & BSVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBX
  • BSVN
  • Stock Information
  • Founded
  • INBX 2010
  • BSVN 2004
  • Country
  • INBX United States
  • BSVN United States
  • Employees
  • INBX N/A
  • BSVN N/A
  • Industry
  • INBX Biotechnology: Pharmaceutical Preparations
  • BSVN Major Banks
  • Sector
  • INBX Health Care
  • BSVN Finance
  • Exchange
  • INBX Nasdaq
  • BSVN Nasdaq
  • Market Cap
  • INBX 345.8M
  • BSVN 410.8M
  • IPO Year
  • INBX 2020
  • BSVN 2018
  • Fundamental
  • Price
  • INBX $25.00
  • BSVN $48.90
  • Analyst Decision
  • INBX Hold
  • BSVN Buy
  • Analyst Count
  • INBX 2
  • BSVN 2
  • Target Price
  • INBX N/A
  • BSVN $53.50
  • AVG Volume (30 Days)
  • INBX 107.2K
  • BSVN 16.7K
  • Earning Date
  • INBX 08-13-2025
  • BSVN 10-10-2025
  • Dividend Yield
  • INBX N/A
  • BSVN 2.08%
  • EPS Growth
  • INBX N/A
  • BSVN 36.51
  • EPS
  • INBX N/A
  • BSVN 4.65
  • Revenue
  • INBX $1,400,000.00
  • BSVN $96,069,000.00
  • Revenue This Year
  • INBX N/A
  • BSVN N/A
  • Revenue Next Year
  • INBX N/A
  • BSVN $4.37
  • P/E Ratio
  • INBX N/A
  • BSVN $10.52
  • Revenue Growth
  • INBX N/A
  • BSVN 22.27
  • 52 Week Low
  • INBX $10.81
  • BSVN $32.49
  • 52 Week High
  • INBX $25.61
  • BSVN $50.26
  • Technical
  • Relative Strength Index (RSI)
  • INBX 65.23
  • BSVN 68.26
  • Support Level
  • INBX $22.40
  • BSVN $44.18
  • Resistance Level
  • INBX $24.48
  • BSVN $46.25
  • Average True Range (ATR)
  • INBX 1.39
  • BSVN 1.41
  • MACD
  • INBX 0.08
  • BSVN 0.22
  • Stochastic Oscillator
  • INBX 87.94
  • BSVN 95.87

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

About BSVN Bank7 Corp. Common stock

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.

Share on Social Networks: